摘要
目的:观察肝硬化Hp感染情况并进行分析。方法:对确诊为肝硬化患者行13C呼气实验测Hp,并对胃、十二指肠疾病患者行13C呼气实验测Hp。结果:肝硬化的胃粘膜Hp感染病例13例,感染率30.95%,非肝硬化的胃粘膜Hp感染病例20例,感染率47.61%,肝硬化的Hp感染率明显低于非肝硬化的Hp感染率,两组资料阳性率有显著差异性(P<0.01)。结论:Hp感染不参与肝硬化胃粘膜病变的发病过程,对肝硬化有胃粘膜病变的患者,无需常规根除、清除治疗。
Objective: We investigated the prevalence of Hp in the gastric mucosa in patients suffering from liver cirrhosis. Methods: Upper endoscopy and ^13C-methacetin breath test were evaluated between two groups respectively. Twenty-two patients with liver cirrhosis and the same number with disease of stomach and duodenum without as a control group were selected. Results: The difference between the two groups was significant (P 〈0.01 ). Of the heptatocirrosis patients, 13(30.95% ) patient were positive for H. pylori infection, much lower than the control group, in which 20(47.61% ) patients were found positive. Conclusions: The data of the study didn't indicate any correlation within the pathologic changes of the gastric mucosa caused by the liver cirrhosis and the presence or the growth of Hp. A routine eradication and elimination is not necessary.
出处
《赣南医学院学报》
2009年第2期213-214,共2页
JOURNAL OF GANNAN MEDICAL UNIVERSITY
关键词
幽门螺旋杆菌感染
肝硬化
胃粘膜病变
Hp infection
liver cirrhosis
pathological changes of gastric mucosa